SILVERARC CAPITAL MANAGEMENT, LLC
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1816307
BOSTON, MA
Position in ACRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,296,889
+$10,296,889 QoQ
Shares Held
1,946,482
Ownership
1.32%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#15
of 149 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Derivatives in ACRS
reported options exposure · as of Sep 30, 2023CallValue
$1,363,150
CallShares
199,000
PutValue
$16,440
PutShares
2,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. ACRS ranks #26 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in ACRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,296,889 | 1,946,482 | Shares | Sole | 2026-08-13 | |
| 2023-09-30 | $16,440 | 2,400 | Put | Sole | 2023-11-13 | |
| 2023-09-30 | $1,363,150 | 199,000 | Call | Sole | 2023-11-13 | |
| 2023-06-30 | $6,755,018 | 651,400 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,273,404 | 219,229 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,780,609 | 220,100 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $5,269,826 | 651,400 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $5,547,039 | 352,193 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,559,034 | 543,776 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $7,532,048 | 539,545 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $4,746,740 | 275,333 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,161,726 | 286,226 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,119,886 | 173,327 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,313,905 | 188,719 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,485,772 | 336,737 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||